EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Xtant Medical Holdings's Enterprise Value is €55.4 Mil.
Xtant Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €6.6 Mil. Therefore, Xtant Medical Holdings's EV-to-FCF for today is 8.37.
The historical rank and industry rank for Xtant Medical Holdings's EV-to-FCF or its related term are showing as below:
FRA:XMS'
s EV-to-FCF Range Over the Past 10 Years
Min: -902.34 Med: -13.51 Max: 221.67
Current: 8.11
During the past 13 years, the highest EV-to-FCF of Xtant Medical Holdings was 221.67. The lowest was -902.34. And the median was -13.51.
FRA:XMS's EV-to-FCF is ranked better than 86.16% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs FRA:XMS: 8.11
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Xtant Medical Holdings (FRA:XMS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Xtant Medical Holdings's PE Ratio (TTM) for today is calculated as:
Xtant Medical Holdings's share price for today is €0.362.
Xtant Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Xtant Medical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xtant Medical Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Xtant Medical Holdings's EV-to-FCF falls into.
Xtant Medical Holdings's current Enterprise Value is €55.4 Mil.
Xtant Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings (FRA:XMS) has a EV-to-FCF of 8.37 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Xtant Medical Holdings and its competitors. According to the industry distribution chart, Xtant Medical Holdings ranks #58 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 13.8%.
Is Xtant Medical Holdings' EV-to-FCF too high?
Xtant Medical Holdings' current EV-to-FCF is 8.37. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. Xtant Medical Holdings' value of 8.37 is 62.9% below this industry median. Based on the distribution chart, Xtant Medical Holdings ranks #58 out of 419 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Xtant Medical Holdings has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' EV-to-FCF compare to POSC and LUNG?
According to the Medical Devices & Instruments industry distribution chart, Xtant Medical Holdings ranks #58 out of 419 companies for EV-to-FCF. This places Xtant Medical Holdings in the top 14% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.57. Xtant Medical Holdings' value of 8.37 is 62.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xtant Medical Holdings's current EV-to-FCF of 8.37 is 62.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Xtant Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xtant Medical Holdings's current EV-to-FCF is 8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Xtant Medical Holdings (FRA:XMS) has a current EV-to-FCF of 8.37. The stock's GF Value™ is €0.53, compared to a current price of €0.36 — trading 31.7% below its estimated fair value. The current EV-to-FCF is 8.37 and 62.9% below the Medical Devices & Instruments industry median of 22.57. Xtant Medical Holdings' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Xtant Medical Holdings (FRA:XMS), the current EV-to-FCF is 8.37 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xtant Medical Holdings (FRA:XMS) Overvalued in 2026?
Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued.
The current stock price of €0.36 is trading 31.7% below its estimated GF Value™ of €0.53.
Key valuation signals for FRA:XMS:
EV-to-FCF: 8.37
GF Value™: €0.53 vs. price of €0.36 (31.7% below fair value)
Industry Position: 62.9% below the Medical Devices & Instruments median (#58 of 419)
No single metric tells the full story. See the FRA:XMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
31GF Score
Get the complete analysis for FRA:XMS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XMS has been successfully added to your 
